Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Head and neck squamous cell carcinoma
2020 Standout
Nasopharyngeal carcinoma
2005 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: Survival after local recurrence
1993
Genetic factors affecting drug disposition in Asian cancer patients
2015
Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography
1996
Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure
1992
Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area
2015
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation
2005
Polymorphisms in the VKORC1 gene are strongly associated with warfarin dosage requirements in patients receiving anticoagulation
2006
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma
2001
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
2010 StandoutNobel
Oral Anticoagulant Therapy
2012 Standout
Combined genetic profiles of components and regulators of the vitamin K-dependent γ-carboxylation system affect individual sensitivity to warfarin
2006
Locally Recurrent Nasopharyngeal Carcinoma: Treatment Results for Patients with Computed Tomography Assessment
1998
Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants
2008
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
2008 Standout
Nasopharyngeal carcinoma
2019 Standout
Concordance of functional in vitro data and epidemiological associations in complex disease genetics
2006
Treatment of head and neck cancer: the role of chemotherapy
1996
Long-term Survival After Surgical Resection for Recurrent Nasopharyngeal Cancer After Radiotherapy Failure
1991
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
2008
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
The Missing Diversity in Human Genetic Studies
2019 Standout
Nasopharyngeal carcinoma
2015 Standout
VKORC1: molecular target of coumarins
2007
Bioenergetic effect of liposomal coenzyme Q10 on myocardial ischemia reperfusion injury
1999
Nerve and Conduction Tissue Injury Caused by Contact with BioGlue
2007
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy
2012
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Management of Extensive Cervical Nodal Metastasis in Nasopharyngeal Carcinoma After Radiotherapy
2001
A genotyping method for VKORC1 1173C>T by Pyrosequencing®technology
2008 StandoutNobel
Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control
1997
What is the Role of Leukocyte Depletion in Cardiac Surgery?
2007
Several-fold increase in risk of overanticoagulation by CYP2C9 mutations
2005
Managing nasopharyngeal carcinoma with intracavitary brachytherapy
2002
Does Systemic Leukocyte Filtration Affect Perioperative Hemorrhage in Cardiac Surgery? A Systematic Review and Meta-Analysis
2007
Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy
2001
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage
2002
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy
2009
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans
2006
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
2006 StandoutNobel
CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese
2006
Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years’ experience at Long Beach Memorial
2000
Pathological Basis of Surgery in the Management of Postradiotherapy Cervical Metastasis in Nasopharyngeal Carcinoma
1992
Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population
2005
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Influence of CYP2C9 and VKORC1 on Warfarin Dose, Anticoagulation Attainment and Maintenance Among European–Americans and African–Americans
2008
Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization
1999
A comparison of staging systems for nasopharyngeal carcinoma
1998
Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival
2003
Chemotherapy for advanced gastric cancer
2017 Standout
The influence of sequence variations in factor VII, γ-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement
2006
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
2017
Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
2001
CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic Dosing
2009
Right Ventricular Function in Cardiovascular Disease, Part I
2008 Standout
Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with Preeclampsia
2012 StandoutNobel
Atrial Septal Defects in the Adult
2006
A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) ina patient on warfarin therapy
2006
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of Ying‐Fu Chen being referenced
Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukocytes during cardiopulmonary bypass
2004
Leukocyte depletion attenuates expression of neutrophil adhesion molecules during cardiopulmonary bypass in human beings
2002
Use of glutaraldehyde solution in the treatment of acute aortic dissections
1994
A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity
2005
Surgical correction of sinus venosus atrial septal defect associated with partial anomalous pulmonary venous connection to high superior vena cava--case report.
1994
Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients
1989
Effectiveness of coenzyme Q10 on myocardial preservation during hypothermic cardioplegic arrest
1994